MedPage Today

Neffy Is About to Hit Shelves: Considerations for Prescribing

The FDA recently approved the first needle-free epinephrine product (neffy), an alternative to injectable epinephrine (EpiPen) for anaphylaxis and other allergic reactions -- and I will be prescribing ...
Nasdaq

ARS Pharmaceuticals Announces FDA Approval of neffy® 1 mg (epinephrine nasal spray) for Type I Allergic Reactions, Including Anaphylaxis, in Pediatric Patients Weighing 15 to ...

SAN DIEGO, March 05, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves ...
Healio

Advocates ‘very excited’ by FDA approval of epinephrine nasal spray

Please provide your email address to receive an email when new articles are posted on . Neffy nasal spray is the first FDA approved needle-free epinephrine alternative. The spray is as effective as ...
Nasdaq

ARS Pharmaceuticals Announces FDA Approval of neffy® 1 mg, First Needle-Free Epinephrine Treatment for Children Ages 4 and Up

neffy 1 mg is the first approved needle-free epinephrine nasal spray for children aged 4 to 30 kg, addressing severe allergic reactions. ARS Pharmaceuticals announced the FDA approval of neffy 1 mg, ...
Healio

Sublingual epinephrine outcomes fall between manual injection, autoinjectors

Please provide your email address to receive an email when new articles are posted on . Sublingual delivery of epinephrine achieved pharmacokinetic and pharmacodynamic results that were comparable ...

California K-12 Schools Now Eligible for neffyinSchools Program, Offering Needle-Free Epinephrine at No Cost for Emergency Use

California joins 23 other states eligible to receive free neffy ® (epinephrine nasal spray) at schoolsSAN DIEGO, (GLOBE NEWSWIRE) ...
manilatimes

California K-12 Schools Now Eligible for neffyinSchools Program, Offering Needle-Free Epinephrine at No Cost for Emergency Use

SAN DIEGO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect ...